COVID-19 IMPORTANT UPDATE
Due to the spread of the Omicron variant of COVID19 and the imposed travel restrictions and social distancing rules, the event will be held in accordance with the German authorities regulations in force. Further instructions regarding this matter will be sent to the registrants a week before the event. We are keen to keep the face-to-face format and meet together.
This third international symposium for researchers and clinicians on Wiskott Aldrich Syndrome is being held in Munich Germany and offers access to the latest research and analysis related to this rare disease.
Meeting participants will gain valuable insights into innovative perspectives in both basic and clinical research. The scientific programme will draw together experts from around the world to discuss breakthroughs in basic research, advances in clinical practice, novel therapeutic approaches and new insights into stem-cell and cellular therapies. An ideal forum to share knowledge, connect with professional colleagues and grow your professional network.
KEYNOTE AND INVITED SPEAKERS
- Expanding WAS/XLT and WASp research.
- Bridging the gap between basic and clinical research to speed up applications
- Foster collaboration among researchers.
- Attract young researchers to focus on WAS/XLT and WASp
Prof. Adrian Thrasher - Institute of child health, London.
Prof. Anna Villa - Telethon Institute for Gene Therapy (SR-Tiget).
Prof. Michael Albert - Dr. von Hauner Children’s Hospital, LMU Munich.
Prof. Bobby Gaspar - Institute of child health, London.
Dr. Sumathi Iyengar - The Wiskott Aldrich Foundation.
Mr. Amir Kedar - The Wiskott Aldrich Syndrome association (R.A.).
This Networking event has received funding from the European Union’s Horizon 2020 research and innovation programme under the EJP RD COFUND-EJP N° 825575
The WAS2022 Symposium was made possible, in part, by a grant provided by the Jeffrey Modell Foundation WIN Program.
© 2021 by WAS2022.ORG